Mechanistically, MLT ameliorates lysosomal dysfunction in renal tubular epithelial cells by activating TFEB-mediated modulation of the miR-205-LRP-1 signaling axis, thereby attenuating renal injury in DKD. The gene discussed is LRP1; the disease is diabetic kidney disease.